Attenuation of the Induction of TLRs 2 and 4 Mitigates Inflammation and Promotes Neurological Recovery After Focal Cerebral Ischemia
The intense inflammatory response triggered in the brain after focal cerebral ischemia is detrimental. Recently, we showed that the suppression of toll-like receptors (TLRs) 2 and 4 attenuates infarct size and reduces the expression of pro-inflammatory cytokines in the ischemic brain. In this study,...
Gespeichert in:
Veröffentlicht in: | Translational stroke research 2021-10, Vol.12 (5), p.923-936 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 936 |
---|---|
container_issue | 5 |
container_start_page | 923 |
container_title | Translational stroke research |
container_volume | 12 |
creator | Nalamolu, Koteswara Rao Challa, Siva Reddy Fornal, Casimir A. Grudzien, Natalia A. Jorgenson, Laura C. Choudry, Mouneeb M. Smith, Nathan J. Palmer, Cassandra J. Pinson, David M. Klopfenstein, Jeffrey D. Veeravalli, Krishna Kumar |
description | The intense inflammatory response triggered in the brain after focal cerebral ischemia is detrimental. Recently, we showed that the suppression of toll-like receptors (TLRs) 2 and 4 attenuates infarct size and reduces the expression of pro-inflammatory cytokines in the ischemic brain. In this study, we further examined the effect of unsuppressed induction of TLRs 2 and 4 on the expression of its downstream signaling molecules and pro-inflammatory cytokines 1 week after reperfusion. The primary purpose of this study was to investigate the effect of simultaneous knockdown of TLRs 2 and 4 on M1/M2 microglial polarization dynamics and post-stroke neurological deficits and the recovery. Transient focal cerebral ischemia was induced in young adult male Sprague-Dawley rats by the middle cerebral artery occlusion (MCAO) procedure using a monofilament suture. Appropriate cohorts of rats were treated with a nanoparticle formulation of TLR2shRNA and TLR4shRNA (T2sh+T4sh) expressing plasmids (1 mg/kg each of T2sh and T4sh) or scrambled sequence inserted vector (vehicle control) expressing plasmids (2 mg/kg) intravenously via tail vein immediately after reperfusion. Animals from various cohorts were euthanized during reperfusion, and the ischemic brain tissue was isolated and utilized for PCR followed by agarose gel electrophoresis, real-time PCR, immunoblot, and immunofluorescence analysis. Appropriate groups were subjected to a battery of standard neurological tests at regular intervals until 14 days after reperfusion. The increased expression of both TLRs 2 and 4 and their downstream signaling molecules including the pro-inflammatory cytokines was observed even at 1-week after reperfusion. T2sh+T4sh treatment immediately after reperfusion attenuated the post-ischemic inflammation, preserved the motor function, and promoted recovery of the sensory and motor functions. We conclude that the post-ischemic induction of TLRs 2 and 4 persists for at least 7 days after reperfusion, contributes to the severity of acute inflammation, and impedes neurological recovery. Unlike previous studies in TLRs 2 or 4 knockout models, results of this study in a pharmacologically relevant preclinical rodent stroke model have translational significance. |
doi_str_mv | 10.1007/s12975-020-00884-z |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8272739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2476845552</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-492cad5e1b14420d1c912847ecf610022f1c989fa48e5725b3462e4db2cc1ea13</originalsourceid><addsrcrecordid>eNp9UcFu1DAQjRAVrUp_gAOyxIVLwJ5MEueCtFpRWGmhqCoSN8txJrupkrjYTqX23A-vl2wL9FBfPHrvzfOMX5K8EfyD4Lz86AVUZZ5y4CnnUmJ6-yI5ErKQacHFr5f7GlFmh8mJ95c8nkxggdmr5DDLEIoC5FFytwiBxkmHzo7Mtixsia3GZjIPwMX63DNgemwYsm9d6DY6kI-attfDMPftyB_ODnbHfKfJ2d5uOqN7dk7GXpO7YYs2kGOndgcuyVHtYrHyZktDp18nB63uPZ3s7-Pk5-nni-XXdH32ZbVcrFODJYYUKzC6yUnUAhF4I0wlQGJJpi3inwC0EZFVq1FSXkJeZ1gAYVODMYK0yI6TT7Pv1VQP1BgaQxxDXblu0O5GWd2p_5mx26qNvVYSSiizKhq83xs4-3siH9TQeUN9r0eyk1eAZSExz3OI0ndPpJd2cmNcT0ElKsx5hUVUwawyznrvqH0cRnC1y1nNOauYs_qTs7qNTW__XeOx5SHVKMhmgY_UuCH39-1nbO8BcK606w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2919450946</pqid></control><display><type>article</type><title>Attenuation of the Induction of TLRs 2 and 4 Mitigates Inflammation and Promotes Neurological Recovery After Focal Cerebral Ischemia</title><source>MEDLINE</source><source>ProQuest Central (Alumni Edition)</source><source>SpringerNature Journals</source><source>ProQuest Central UK/Ireland</source><source>ProQuest Central</source><creator>Nalamolu, Koteswara Rao ; Challa, Siva Reddy ; Fornal, Casimir A. ; Grudzien, Natalia A. ; Jorgenson, Laura C. ; Choudry, Mouneeb M. ; Smith, Nathan J. ; Palmer, Cassandra J. ; Pinson, David M. ; Klopfenstein, Jeffrey D. ; Veeravalli, Krishna Kumar</creator><creatorcontrib>Nalamolu, Koteswara Rao ; Challa, Siva Reddy ; Fornal, Casimir A. ; Grudzien, Natalia A. ; Jorgenson, Laura C. ; Choudry, Mouneeb M. ; Smith, Nathan J. ; Palmer, Cassandra J. ; Pinson, David M. ; Klopfenstein, Jeffrey D. ; Veeravalli, Krishna Kumar</creatorcontrib><description>The intense inflammatory response triggered in the brain after focal cerebral ischemia is detrimental. Recently, we showed that the suppression of toll-like receptors (TLRs) 2 and 4 attenuates infarct size and reduces the expression of pro-inflammatory cytokines in the ischemic brain. In this study, we further examined the effect of unsuppressed induction of TLRs 2 and 4 on the expression of its downstream signaling molecules and pro-inflammatory cytokines 1 week after reperfusion. The primary purpose of this study was to investigate the effect of simultaneous knockdown of TLRs 2 and 4 on M1/M2 microglial polarization dynamics and post-stroke neurological deficits and the recovery. Transient focal cerebral ischemia was induced in young adult male Sprague-Dawley rats by the middle cerebral artery occlusion (MCAO) procedure using a monofilament suture. Appropriate cohorts of rats were treated with a nanoparticle formulation of TLR2shRNA and TLR4shRNA (T2sh+T4sh) expressing plasmids (1 mg/kg each of T2sh and T4sh) or scrambled sequence inserted vector (vehicle control) expressing plasmids (2 mg/kg) intravenously via tail vein immediately after reperfusion. Animals from various cohorts were euthanized during reperfusion, and the ischemic brain tissue was isolated and utilized for PCR followed by agarose gel electrophoresis, real-time PCR, immunoblot, and immunofluorescence analysis. Appropriate groups were subjected to a battery of standard neurological tests at regular intervals until 14 days after reperfusion. The increased expression of both TLRs 2 and 4 and their downstream signaling molecules including the pro-inflammatory cytokines was observed even at 1-week after reperfusion. T2sh+T4sh treatment immediately after reperfusion attenuated the post-ischemic inflammation, preserved the motor function, and promoted recovery of the sensory and motor functions. We conclude that the post-ischemic induction of TLRs 2 and 4 persists for at least 7 days after reperfusion, contributes to the severity of acute inflammation, and impedes neurological recovery. Unlike previous studies in TLRs 2 or 4 knockout models, results of this study in a pharmacologically relevant preclinical rodent stroke model have translational significance.</description><identifier>ISSN: 1868-4483</identifier><identifier>EISSN: 1868-601X</identifier><identifier>DOI: 10.1007/s12975-020-00884-z</identifier><identifier>PMID: 33426628</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Antibodies ; Biomedical and Life Sciences ; Biomedicine ; Brain damage ; Brain Ischemia ; Cardiology ; Cloning ; Cytokines ; Genes ; Infarction, Middle Cerebral Artery ; Inflammation ; Inflammation - etiology ; Ischemia ; Laboratories ; Male ; Manufacturers ; Neurology ; Neurosciences ; Neurosurgery ; Original Article ; Pathogenesis ; Plasmids ; Polymerase chain reaction ; Rats ; Rats, Sprague-Dawley ; Reperfusion Injury - drug therapy ; Stroke ; Vascular Surgery</subject><ispartof>Translational stroke research, 2021-10, Vol.12 (5), p.923-936</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-492cad5e1b14420d1c912847ecf610022f1c989fa48e5725b3462e4db2cc1ea13</citedby><cites>FETCH-LOGICAL-c474t-492cad5e1b14420d1c912847ecf610022f1c989fa48e5725b3462e4db2cc1ea13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12975-020-00884-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2919450946?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,315,781,785,886,21389,21390,27925,27926,33531,33532,33745,33746,41489,42558,43660,43806,51320,64386,64388,64390,72470</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33426628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nalamolu, Koteswara Rao</creatorcontrib><creatorcontrib>Challa, Siva Reddy</creatorcontrib><creatorcontrib>Fornal, Casimir A.</creatorcontrib><creatorcontrib>Grudzien, Natalia A.</creatorcontrib><creatorcontrib>Jorgenson, Laura C.</creatorcontrib><creatorcontrib>Choudry, Mouneeb M.</creatorcontrib><creatorcontrib>Smith, Nathan J.</creatorcontrib><creatorcontrib>Palmer, Cassandra J.</creatorcontrib><creatorcontrib>Pinson, David M.</creatorcontrib><creatorcontrib>Klopfenstein, Jeffrey D.</creatorcontrib><creatorcontrib>Veeravalli, Krishna Kumar</creatorcontrib><title>Attenuation of the Induction of TLRs 2 and 4 Mitigates Inflammation and Promotes Neurological Recovery After Focal Cerebral Ischemia</title><title>Translational stroke research</title><addtitle>Transl. Stroke Res</addtitle><addtitle>Transl Stroke Res</addtitle><description>The intense inflammatory response triggered in the brain after focal cerebral ischemia is detrimental. Recently, we showed that the suppression of toll-like receptors (TLRs) 2 and 4 attenuates infarct size and reduces the expression of pro-inflammatory cytokines in the ischemic brain. In this study, we further examined the effect of unsuppressed induction of TLRs 2 and 4 on the expression of its downstream signaling molecules and pro-inflammatory cytokines 1 week after reperfusion. The primary purpose of this study was to investigate the effect of simultaneous knockdown of TLRs 2 and 4 on M1/M2 microglial polarization dynamics and post-stroke neurological deficits and the recovery. Transient focal cerebral ischemia was induced in young adult male Sprague-Dawley rats by the middle cerebral artery occlusion (MCAO) procedure using a monofilament suture. Appropriate cohorts of rats were treated with a nanoparticle formulation of TLR2shRNA and TLR4shRNA (T2sh+T4sh) expressing plasmids (1 mg/kg each of T2sh and T4sh) or scrambled sequence inserted vector (vehicle control) expressing plasmids (2 mg/kg) intravenously via tail vein immediately after reperfusion. Animals from various cohorts were euthanized during reperfusion, and the ischemic brain tissue was isolated and utilized for PCR followed by agarose gel electrophoresis, real-time PCR, immunoblot, and immunofluorescence analysis. Appropriate groups were subjected to a battery of standard neurological tests at regular intervals until 14 days after reperfusion. The increased expression of both TLRs 2 and 4 and their downstream signaling molecules including the pro-inflammatory cytokines was observed even at 1-week after reperfusion. T2sh+T4sh treatment immediately after reperfusion attenuated the post-ischemic inflammation, preserved the motor function, and promoted recovery of the sensory and motor functions. We conclude that the post-ischemic induction of TLRs 2 and 4 persists for at least 7 days after reperfusion, contributes to the severity of acute inflammation, and impedes neurological recovery. Unlike previous studies in TLRs 2 or 4 knockout models, results of this study in a pharmacologically relevant preclinical rodent stroke model have translational significance.</description><subject>Animals</subject><subject>Antibodies</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain damage</subject><subject>Brain Ischemia</subject><subject>Cardiology</subject><subject>Cloning</subject><subject>Cytokines</subject><subject>Genes</subject><subject>Infarction, Middle Cerebral Artery</subject><subject>Inflammation</subject><subject>Inflammation - etiology</subject><subject>Ischemia</subject><subject>Laboratories</subject><subject>Male</subject><subject>Manufacturers</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Original Article</subject><subject>Pathogenesis</subject><subject>Plasmids</subject><subject>Polymerase chain reaction</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion Injury - drug therapy</subject><subject>Stroke</subject><subject>Vascular Surgery</subject><issn>1868-4483</issn><issn>1868-601X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9UcFu1DAQjRAVrUp_gAOyxIVLwJ5MEueCtFpRWGmhqCoSN8txJrupkrjYTqX23A-vl2wL9FBfPHrvzfOMX5K8EfyD4Lz86AVUZZ5y4CnnUmJ6-yI5ErKQacHFr5f7GlFmh8mJ95c8nkxggdmr5DDLEIoC5FFytwiBxkmHzo7Mtixsia3GZjIPwMX63DNgemwYsm9d6DY6kI-attfDMPftyB_ODnbHfKfJ2d5uOqN7dk7GXpO7YYs2kGOndgcuyVHtYrHyZktDp18nB63uPZ3s7-Pk5-nni-XXdH32ZbVcrFODJYYUKzC6yUnUAhF4I0wlQGJJpi3inwC0EZFVq1FSXkJeZ1gAYVODMYK0yI6TT7Pv1VQP1BgaQxxDXblu0O5GWd2p_5mx26qNvVYSSiizKhq83xs4-3siH9TQeUN9r0eyk1eAZSExz3OI0ndPpJd2cmNcT0ElKsx5hUVUwawyznrvqH0cRnC1y1nNOauYs_qTs7qNTW__XeOx5SHVKMhmgY_UuCH39-1nbO8BcK606w</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Nalamolu, Koteswara Rao</creator><creator>Challa, Siva Reddy</creator><creator>Fornal, Casimir A.</creator><creator>Grudzien, Natalia A.</creator><creator>Jorgenson, Laura C.</creator><creator>Choudry, Mouneeb M.</creator><creator>Smith, Nathan J.</creator><creator>Palmer, Cassandra J.</creator><creator>Pinson, David M.</creator><creator>Klopfenstein, Jeffrey D.</creator><creator>Veeravalli, Krishna Kumar</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211001</creationdate><title>Attenuation of the Induction of TLRs 2 and 4 Mitigates Inflammation and Promotes Neurological Recovery After Focal Cerebral Ischemia</title><author>Nalamolu, Koteswara Rao ; Challa, Siva Reddy ; Fornal, Casimir A. ; Grudzien, Natalia A. ; Jorgenson, Laura C. ; Choudry, Mouneeb M. ; Smith, Nathan J. ; Palmer, Cassandra J. ; Pinson, David M. ; Klopfenstein, Jeffrey D. ; Veeravalli, Krishna Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-492cad5e1b14420d1c912847ecf610022f1c989fa48e5725b3462e4db2cc1ea13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain damage</topic><topic>Brain Ischemia</topic><topic>Cardiology</topic><topic>Cloning</topic><topic>Cytokines</topic><topic>Genes</topic><topic>Infarction, Middle Cerebral Artery</topic><topic>Inflammation</topic><topic>Inflammation - etiology</topic><topic>Ischemia</topic><topic>Laboratories</topic><topic>Male</topic><topic>Manufacturers</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Original Article</topic><topic>Pathogenesis</topic><topic>Plasmids</topic><topic>Polymerase chain reaction</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion Injury - drug therapy</topic><topic>Stroke</topic><topic>Vascular Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nalamolu, Koteswara Rao</creatorcontrib><creatorcontrib>Challa, Siva Reddy</creatorcontrib><creatorcontrib>Fornal, Casimir A.</creatorcontrib><creatorcontrib>Grudzien, Natalia A.</creatorcontrib><creatorcontrib>Jorgenson, Laura C.</creatorcontrib><creatorcontrib>Choudry, Mouneeb M.</creatorcontrib><creatorcontrib>Smith, Nathan J.</creatorcontrib><creatorcontrib>Palmer, Cassandra J.</creatorcontrib><creatorcontrib>Pinson, David M.</creatorcontrib><creatorcontrib>Klopfenstein, Jeffrey D.</creatorcontrib><creatorcontrib>Veeravalli, Krishna Kumar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Translational stroke research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nalamolu, Koteswara Rao</au><au>Challa, Siva Reddy</au><au>Fornal, Casimir A.</au><au>Grudzien, Natalia A.</au><au>Jorgenson, Laura C.</au><au>Choudry, Mouneeb M.</au><au>Smith, Nathan J.</au><au>Palmer, Cassandra J.</au><au>Pinson, David M.</au><au>Klopfenstein, Jeffrey D.</au><au>Veeravalli, Krishna Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attenuation of the Induction of TLRs 2 and 4 Mitigates Inflammation and Promotes Neurological Recovery After Focal Cerebral Ischemia</atitle><jtitle>Translational stroke research</jtitle><stitle>Transl. Stroke Res</stitle><addtitle>Transl Stroke Res</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>12</volume><issue>5</issue><spage>923</spage><epage>936</epage><pages>923-936</pages><issn>1868-4483</issn><eissn>1868-601X</eissn><abstract>The intense inflammatory response triggered in the brain after focal cerebral ischemia is detrimental. Recently, we showed that the suppression of toll-like receptors (TLRs) 2 and 4 attenuates infarct size and reduces the expression of pro-inflammatory cytokines in the ischemic brain. In this study, we further examined the effect of unsuppressed induction of TLRs 2 and 4 on the expression of its downstream signaling molecules and pro-inflammatory cytokines 1 week after reperfusion. The primary purpose of this study was to investigate the effect of simultaneous knockdown of TLRs 2 and 4 on M1/M2 microglial polarization dynamics and post-stroke neurological deficits and the recovery. Transient focal cerebral ischemia was induced in young adult male Sprague-Dawley rats by the middle cerebral artery occlusion (MCAO) procedure using a monofilament suture. Appropriate cohorts of rats were treated with a nanoparticle formulation of TLR2shRNA and TLR4shRNA (T2sh+T4sh) expressing plasmids (1 mg/kg each of T2sh and T4sh) or scrambled sequence inserted vector (vehicle control) expressing plasmids (2 mg/kg) intravenously via tail vein immediately after reperfusion. Animals from various cohorts were euthanized during reperfusion, and the ischemic brain tissue was isolated and utilized for PCR followed by agarose gel electrophoresis, real-time PCR, immunoblot, and immunofluorescence analysis. Appropriate groups were subjected to a battery of standard neurological tests at regular intervals until 14 days after reperfusion. The increased expression of both TLRs 2 and 4 and their downstream signaling molecules including the pro-inflammatory cytokines was observed even at 1-week after reperfusion. T2sh+T4sh treatment immediately after reperfusion attenuated the post-ischemic inflammation, preserved the motor function, and promoted recovery of the sensory and motor functions. We conclude that the post-ischemic induction of TLRs 2 and 4 persists for at least 7 days after reperfusion, contributes to the severity of acute inflammation, and impedes neurological recovery. Unlike previous studies in TLRs 2 or 4 knockout models, results of this study in a pharmacologically relevant preclinical rodent stroke model have translational significance.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33426628</pmid><doi>10.1007/s12975-020-00884-z</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1868-4483 |
ispartof | Translational stroke research, 2021-10, Vol.12 (5), p.923-936 |
issn | 1868-4483 1868-601X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8272739 |
source | MEDLINE; ProQuest Central (Alumni Edition); SpringerNature Journals; ProQuest Central UK/Ireland; ProQuest Central |
subjects | Animals Antibodies Biomedical and Life Sciences Biomedicine Brain damage Brain Ischemia Cardiology Cloning Cytokines Genes Infarction, Middle Cerebral Artery Inflammation Inflammation - etiology Ischemia Laboratories Male Manufacturers Neurology Neurosciences Neurosurgery Original Article Pathogenesis Plasmids Polymerase chain reaction Rats Rats, Sprague-Dawley Reperfusion Injury - drug therapy Stroke Vascular Surgery |
title | Attenuation of the Induction of TLRs 2 and 4 Mitigates Inflammation and Promotes Neurological Recovery After Focal Cerebral Ischemia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T14%3A19%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attenuation%20of%20the%20Induction%20of%20TLRs%202%20and%204%20Mitigates%20Inflammation%20and%20Promotes%20Neurological%20Recovery%20After%20Focal%20Cerebral%20Ischemia&rft.jtitle=Translational%20stroke%20research&rft.au=Nalamolu,%20Koteswara%20Rao&rft.date=2021-10-01&rft.volume=12&rft.issue=5&rft.spage=923&rft.epage=936&rft.pages=923-936&rft.issn=1868-4483&rft.eissn=1868-601X&rft_id=info:doi/10.1007/s12975-020-00884-z&rft_dat=%3Cproquest_pubme%3E2476845552%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2919450946&rft_id=info:pmid/33426628&rfr_iscdi=true |